Provided by Tiger Trade Technology Pte. Ltd.

FUNDX FUTURE FUND OPPORTUNITIES ETF

29.13
+0.15950.55%
Post-market: 29.130.00000.00%16:10 EDT
Volume:27.20K
Turnover:790.94K
Market Cap:233.45M
PE:- -
High:29.13
Open:28.84
Low:28.84
Close:28.97
52wk High:31.30
52wk Low:25.44
Shares:8.02M
Float Shares:8.02M
Volume Ratio:1.15
T/O Rate:0.34%
Dividend:0.49
Dividend Rate:1.70%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Analysts’ Top NA Picks: High Roller Technologies, Inc. (ROLR), Halozyme (HALO)

TIPRANKS
·
Yesterday

H.C. Wainwright views Novartis, Alteogen pact as negative for Halozyme

TIPRANKS
·
Yesterday

Halozyme CEO, CFO to Speak at Wells Fargo Healthcare Conference Fireside Chat

Reuters
·
Sep 02

Guardant Health Price Target Maintained with a $195.00/Share by BTIG

Dow Jones
·
Sep 02

Barfresh Food Names CEO Delle Coste Interim CFO as Lisa Roger Retires

Reuters
·
Sep 02

Analysts Are Bullish on Top Healthcare Stocks: Medtronic (MDT), Guardant Health (GH)

TIPRANKS
·
Sep 02

Guardant Health Shield Blood Test Wins Carelon Coverage for Colorectal Cancer Screening

Reuters
·
Sep 01

Does Guardant Health’s (GH) Patent Appeal Reshape Its Competitive Moat More Than Its Royalty Bill?

Simply Wall St.
·
Aug 30

Is Halozyme Therapeutics (HALO) Overvalued After Its New Board Appointment?

Simply Wall St.
·
Aug 29

FireFox Gold Builds Mustajärvi East Zone With Strong Infill Drill Results

TIPRANKS
·
Aug 25

Guardant Health Co-CEO AmirAli Talasaz Disposes of USD 6.35 Million in Common Shares

Reuters
·
Aug 25

Guardant Health to Appeal Delaware Court Ruling in Patent Dispute; Shares Fall

MT Newswires Live
·
Aug 25

Guardant Health to appeal federal district court judgment in TwinStrand case

TIPRANKS
·
Aug 25

Guardant Health, Inc.: Remains Confident That it Did not Infringe Asserted Patents

THOMSON REUTERS
·
Aug 25

Guardant Health, - Current Guardant Reveal and Shield Products Excluded from Final Court Order

THOMSON REUTERS
·
Aug 25

Guardant Health to Appeal Federal District Court Judgment

THOMSON REUTERS
·
Aug 25

U.S. Court Orders Guardant to Pay $245 Million in DNA Sequencing Patent Dispute

Reuters
·
Aug 25

Sector Update: Healthcare

MT Newswires Live
·
Aug 24

Guardant Health Loses $245.2 Million Patent Infringement Case

MT Newswires Live
·
Aug 24

Twinstrand: Court Awards Co and Uw over $245.2 Mln in Damages, Accrued Royalties & Interest for Infringement That Occurred Through May 31, 2026

THOMSON REUTERS
·
Aug 24